Woman Claims Pregnancy While Using Mounjaro, Husband on Ozempic, Credits Drugs for Infertility Success
A woman's account of conceiving while using Mounjaro, alongside her husband's use of Ozempic, has sparked discussion about the off-label use of these weight-loss drugs for fertility.
A woman who struggled with infertility for five years has shared her experience of becoming pregnant while using Mounjaro, a drug primarily prescribed for type 2 diabetes and weight management. Her husband was concurrently using Ozempic, another diabetes and weight-loss medication.
The woman, Rhiannon Picton-James, detailed her journey in an online publication, stating that her period was weeks late, which, given her history, led her to suspect pregnancy. She expressed belief that the medications played a role in finally achieving her long-desired pregnancy.
Picton-James's account raises questions about the potential impact of GLP-1 receptor agonists, such as Mounjaro and Ozempic, on fertility. While these drugs are FDA-approved for specific indications, their use for fertility or pregnancy is not officially sanctioned. Medical professionals often advise caution regarding off-label use, particularly during pregnancy, due to limited data on potential risks to the developing fetus.
She noted that after the birth of her first child, Ada, at age 28, she faced years of difficulty conceiving again. The positive pregnancy test in April, after she began taking Mounjaro in January, brought both joy and concern.
While Picton-James's personal experience has led to her conviction about the medications' efficacy in her case, the medical community generally emphasizes the need for consultation with healthcare providers regarding any fertility concerns or before using prescription medications, especially during pregnancy. Further research is ongoing to understand the complex interplay between these medications and reproductive health.